Topography Guided LASIK by Different Protocols for Treatment of Astigmatism

Candidates for refractive surgery above 18 years with myopic astigmatism and no previous ocular surgery.

Sample size 60 eyes. surgery:

• 60 eyes of myopic topography-guided LASIK procedures with the same refractive platform (FS200 femtosecond to create a flap between90: 110 μm with diameter 8:9 mm and EX500 excimer lasers) will be randomized for treatment as follows:
• Group A: 20 eyes will be treated using Contoura vision with the standard manifest refraction.
• Group B: 20 eyes will be treated with Contoura vision using the topographic astigmatic power and axis and without change in the spherical power (using the same spherical power as the manifest refraction).
• Group C [TMR]: 20 eyes will be treated with Contoura vision using the topographic astigmatic power and axis and modifying the spherical power to obtain the same spherical equivalent as the manifest refraction. This is done by subtracting half of the difference between topographic astigmatic power and the manifest astigmatic power from the spherical power (topography-modified treatment refraction).
• The standard postoperative treatment is combined steroids and antibiotics eye drops 5 times daily for one week ,then three times daily for three days and lubricant eye drops 5 times daily for six months.

Postoperatively, the patients will be examined at 1 week, 1 month and 3 months. All postoperative follow-up visits included measurement of UDVA, CDVA (if indicated) and refraction, besides full ophthalmological examination and performing pentacam and topolyzer after 3 months

Inclusion criteria

• Stable refractive error: Myopic astigmatism ≥ -1.5 D
• Valid Topolyzer maps (at least four out of eight right maps with green analyzed area and the registration box is green).

Exclusion criteria

• Estimated postoperative residual stromal bed thickness of less than 300µm.
• Glaucomatous patients.
• Patients with keratoconus.
• Patients with pervious refractive surgery.
• History of previous ocular trauma or surgery.
• History of recent herpetic ulcer or viral keratitis.
• Basement membrane disease, history of recurrent corneal erosions.
• Sicca syndrome, dry eye.